ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

174
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
18 Nov 2024 01:19

Merger Arb Mondays (18 Nov) - Henlius, GAPack, Xingda, Seven & I, Fuji Soft, NEC Networks, Macromill

This week, the highest gross spreads are Renewable Japan (80.3%), Henlius (22.1%), Macromill (18.4%), Seven & I (14.8%), Canvest (14.0%), GA Pack...

Logo
354 Views
Share
28 Oct 2024 01:26

Merger Arb Mondays (28 Oct) - Henlius, Canvest, CPMC, Seven & I, Shinko, Capitol, Auswide

This week, the highest gross spreads are Seven & I (22.3%), Henlius (13.9%), Canvest (11.1%), GA Pack (10.9%), Shinko Electric (9.9%), Haitong...

Logo
412 Views
Share
16 Oct 2024 08:55

Shanghai Henlius Biotech (2696.HK) Privatization Update- Looks Like "An Agreement" Has Been Reached?

Fosun is confident in the success of Henlius' privatization​, which hints at vote consensus. What Fosun wants is investment income brought by...

Logo
446 Views
Share
29 Sep 2024 16:02

China Healthcare Weekly (Sep29)- Henlius Privatization Update, NHSA Fee Control, Hansoh Is Exception

The approval process of Henlius' privatization is slow, but the deal will get up. Medical insurance fee control policies will continue. Different...

Logo
352 Views
Share
23 Sep 2024 00:18

Merger Arb Mondays (23 Sep) - Henlius, GA Pack, China TCM, Canvest, Trancom, Fuji Soft, Platinum

This week, the highest gross spreads are Canvest (8.6%), Shinko Electric (7.2%), GA Pack (6.9%), Henlius (6.7%), China TCM (5.7%), Capitol Health...

Logo
369 Views
Share
x